GLP-1 mobility claims: what tirzepatide actually does to your body

What did @katasky actually say?

Honestly, the transcript here is mostly song lyrics, not a health claim. The creator lip-syncs to a defiant track while the real message lives in the caption: after 2.5 years on a tirzepatide journey, she can move in ways she never could before. She calls it a "non-scale victory" and frames the whole thing as survival, not just weight loss. That framing is worth taking seriously.

The video does not make specific dosing claims, does not name a brand, and does not promise anyone else the same result. It is personal testimony, which carries a different evidential weight than a medical claim. But the implicit message, that GLP-1 medications can dramatically change physical function and mobility, is something we can actually fact-check.

Does the science back this up?

Yes, with some important nuance. The connection between weight reduction and improved physical mobility is well-documented, and tirzepatide specifically has generated compelling data on functional outcomes beyond the scale.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide users achieving up to 22.5% body weight reduction at the highest dose over 72 weeks. Carrying less weight directly reduces mechanical load on joints, which is one of the more straightforward mechanisms behind improved movement.

But there is more going on than just weight. A 2023 analysis published in Obesity (Wadden et al.) found that GLP-1 receptor agonist users reported meaningful improvements in physical function scores, independent of how much weight they lost. Inflammation reduction, which tirzepatide appears to drive through both GIP and GLP-1 receptor activity, likely plays a role. Chronic low-grade inflammation is a significant contributor to joint pain and mobility limitations, and targeting it matters beyond the number on the scale.

What did they get wrong (or right)?

She got the framing right. Calling improved mobility a "non-scale victory" is actually more scientifically precise than people give it credit for. Weight loss trials have been criticized for decades for fixating on kilograms rather than functional outcomes. Quality of life, physical capacity, and pain reduction are increasingly recognized as primary endpoints in obesity research, not secondary afterthoughts.

What is harder to verify is the 2.5-year timeline attribution. Mobility improvements can come from weight loss, from reduced inflammation, from increased activity enabled by less joint pain, or from lifestyle changes that accompany starting a medication. Isolating tirzepatide as the cause is not something a TikTok video can do, and she does not try to. That restraint is worth noting.

She does not claim it will work for everyone, does not name a dose, and does not compare compounded to brand-name product. That puts her ahead of a significant portion of GLP-1 content on this platform.

What should you actually know?

If you are considering a GLP-1 medication because you want to move better, not just weigh less, the evidence actually supports that goal. A 2022 study in JAMA Internal Medicine (Rubino et al.) found that semaglutide users showed improvements in physical functioning scores that exceeded what would be predicted by weight loss alone, suggesting direct or indirect drug effects on musculoskeletal function.

Tirzepatide, as a dual GIP and GLP-1 receptor agonist, has a different mechanism than semaglutide and the long-term functional outcome data is still accumulating. The SURMOUNT-OSA trial (2024) added cardiovascular and sleep apnea data, but mobility-specific long-term studies are limited. We do not yet have a 5-year dataset on tirzepatide and joint health the way we do for some older interventions.

Personal testimony like this video is not clinical evidence. It is also not worthless. It tells you what outcomes real patients are experiencing and what they value. What it cannot tell you is whether you will have the same result, on the same timeline, for the same reasons.

Bottom line: inspirational and mostly honest

This video is not making a medical claim. It is sharing a personal milestone. The implicit claim that GLP-1 medications can improve physical function over time is supported by the literature. The creator does not overstate her case, does not prescribe anything, and does not promise outcomes. In the context of GLP-1 content on TikTok, that is a higher bar than most clear.